AI optimizes existing knowledge but doesn't expedite drug approval or reduce costs compared to traditional methods. Explore ...
The Birmingham Biotechnology Hub will receive funding to use artificial intelligence to shorten drug development to provide ...
Y Combinator's Surbhi Sarna has raised $30 million for Collate, a startup aiming to automate the tedious parts of running a ...
On Wednesday the U.S. Department of Commerce announced it would implement new export controls on certain biotechnology ...
Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company has ...
Combining human efforts, nature, and AI in what Noubar Afeyan calls “polyintelligence” could solve problems such as climate ...